AllianceBernstein’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$195K Hold
14,141
﹤0.01% 3155
2026
Q1
$255K Hold
14,141
﹤0.01% 2953
2025
Q4
$255K Sell
14,141
-1,240
-8% -$22.3K ﹤0.01% 2973
2025
Q3
$285K Sell
15,381
-13,252
-46% -$208K ﹤0.01% 2959
2025
Q2
$458K Hold
28,633
﹤0.01% 2692
2025
Q1
$556K Hold
28,633
﹤0.01% 2514
2024
Q4
$631K Buy
28,633
+14,981
+110% +$288K ﹤0.01% 2536
2024
Q3
$230K Hold
13,652
﹤0.01% 2998
2024
Q2
$163K Hold
13,652
﹤0.01% 3063
2024
Q1
$151K Hold
13,652
﹤0.01% 2972
2023
Q4
$118K Hold
13,652
﹤0.01% 3048
2023
Q3
$104K Hold
13,652
﹤0.01% 3059
2023
Q2
$98.3K Hold
13,652
﹤0.01% 3081
2023
Q1
$83.1K Hold
13,652
﹤0.01% 3045
2022
Q4
$59.5K Hold
13,652
﹤0.01% 3161
2022
Q3
$54K Buy
+13,652
New +$68.4K ﹤0.01% 3174

Other funds holding CLBT

AllianceBernstein's CLBT Position: Q2 2026 in Review

AllianceBernstein held its Cellebrite (CLBT) position steady in Q2 2026 at 14,141 shares worth $195K. The position accounts for ﹤0.01% of the portfolio, ranked #3155.

AllianceBernstein first reported a position in CLBT in Q3 2022 and has held it in 16 quarters since. The position peaked at $631K in Q4 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • AllianceBernstein held 14,141 shares of Cellebrite worth $195K as of Q2 2026.
  • AllianceBernstein left its Cellebrite share count unchanged in Q2 2026.
  • Cellebrite made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #3155 holding.
  • AllianceBernstein first reported a position in Cellebrite in Q3 2022 and has held it in 16 quarters since.
  • AllianceBernstein's Cellebrite position peaked at $631K in Q4 2024.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.